9 Papers
14 Citations
Qing He is an academic researcher from Fourth Military Medical University. The author has contributed to research in topics: Reporter gene & Medicine. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
mRNA cancer vaccines: Advances, trends and challenges
TL;DR: In 2019, the U.S. Food and Drug Administration (FDA) approved the first mRNA-based coronavirus disease 2019 (COVID-19) vaccine produced by Pfizer and BioNTech, which generated enthusiasm for mRNA vaccine research and development as discussed by the authors .
87
Analysis of IL-6 and IL-1β release in cryopreserved pooled human whole blood stimulated with endotoxin.
TL;DR: Cryopreserved pooled blood is a convenient and viable alternative for evaluating in vitro pyrogenicity and promotes safety for the user because it is released only after pretesting for infection parameters and has lower variation than fresh donations from a variety of donors.
12
Anti-Gastrins Antiserum Combined with Lowered Dosage Cytotoxic Drugs to Inhibit the Growth of Human Gastric Cancer SGC7901 Cells in Nude Mice
TL;DR: The immunological treatment had little of the toxicities and side-effects of the full chemotherapy doses alone, which was effected by using a significant decrease in the dosage of chemotherapeutic drugs, while maintaining the same level of efficacy at reduction of tumor growth.
Immunogenicity and safety of a novel tetanus toxoid-conjugated anti-gastrin vaccine in BALB/c mice.
TL;DR: In this paper, a tetanus toxoid (TT) was used as a protein carrier to enhance the antigenic epitopes' humoural and cellular immune responses, unlike the antigenics epitopes alone or the immunogen's adjuvant emulsion system (AES), all of which failed to provoke any obvious immune response.
5
A novel reporter gene assay for pyrogen detection
TL;DR: The results of this study suggest that the novel RGA has a wide pyrogen detection spectrum and is sufficiently sensitive, stable, and accurate for various applications.
5